Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27,

Related Keywords

Denmark ,Thomas Pedersen ,Thomas Jensen ,Nasdaq Stock Market ,Exchange Commission ,Allarity Therapeutics Inc ,Nasdaq ,Linkedin ,Company Contact ,Carrotize Pr Communications ,Allarity Therapeutics ,General Counsel ,Listing Rule ,Nasdaq Listing Rule ,Private Securities Litigation Reform Act ,Region ,